Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koren

Showing results (101-110 of 5,481) with videos related to

Pageof 549
Sort By:
Harefuah|October 22, 2018
[MACCABI HEALTHCARE SERVICES - INNOVATION AS A WAY OF LIFE]Gideon Koren
Neurotoxicology and Teratology|April 19, 2020
WITHDRAWN: Poster presentationsGideon Koren
Canadian Family Physician Medecin De Famille Canadien|August 10, 2001
Maternal obesity and risk of neural tube defectsG Koren
Reproductive Toxicology (Elmsford, N.Y.)|June 8, 2001
Glyburide and fetal safety; transplacental pharmacokinetic considerationsG Koren
Pediatric Research|June 1, 2001
The use of glyburide in gestational diabetes--an ideal example of "bench to bedside"G Koren
Reproductive Toxicology (Elmsford, N.Y.)|January 1, 1992
A quality assurance program for teratogen information servicesG Koren
Paediatric Drugs|January 9, 2009
Training clinicians in Maternal-Fetal Pharmacology: closing a conceptual gapGideon Koren
Canadian Family Physician Medecin De Famille Canadien|February 7, 2007
Changes in drug handling during pregnancy: what it might mean for your patientsGideon Koren
Paediatrics & Child Health|November 26, 2008
A primer of paediatric toxic syndromes or 'toxidromes'Gideon Koren
Obstetrics and Gynecology|May 25, 2011
Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum painGideon Koren
Pageof 549

Showing results (101-110 of 5,481) with videos related to

Sort By:
Pageof 549
Harefuah|October 22, 2018
[MACCABI HEALTHCARE SERVICES - INNOVATION AS A WAY OF LIFE]Gideon Koren
Neurotoxicology and Teratology|April 19, 2020
WITHDRAWN: Poster presentationsGideon Koren
Canadian Family Physician Medecin De Famille Canadien|August 10, 2001
Maternal obesity and risk of neural tube defectsG Koren
Reproductive Toxicology (Elmsford, N.Y.)|June 8, 2001
Glyburide and fetal safety; transplacental pharmacokinetic considerationsG Koren
Pediatric Research|June 1, 2001
The use of glyburide in gestational diabetes--an ideal example of "bench to bedside"G Koren
Reproductive Toxicology (Elmsford, N.Y.)|January 1, 1992
A quality assurance program for teratogen information servicesG Koren
Paediatric Drugs|January 9, 2009
Training clinicians in Maternal-Fetal Pharmacology: closing a conceptual gapGideon Koren
Canadian Family Physician Medecin De Famille Canadien|February 7, 2007
Changes in drug handling during pregnancy: what it might mean for your patientsGideon Koren
Paediatrics & Child Health|November 26, 2008
A primer of paediatric toxic syndromes or 'toxidromes'Gideon Koren
Obstetrics and Gynecology|May 25, 2011
Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum painGideon Koren
Pageof 549